Clin2
NCT06658002Possibly a fitRecruiting

Testing stronger eye drops for fungal eye infections

Fungal KeratitisCorneal Ulcer

Treatments studied

Part of Eyes & vision, Infections clinical trials.

This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a fungal eye infection confirmed by lab test (smear or culture).
  • Your vision in the infected eye is between 20/40 and 20/400.
  • You are 18 years or older.
  • You are willing to follow up at the hospital.
  • You are not already taking cyclosporine eye drops.
  • You do not have severe eye damage like a hole in the cornea or need a cornea transplant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06463678Not yet recruiting· Phase 2
Testing a new eye drop for fungal eye infections

This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.

NCT07743489Not yet recruiting· Phase 3
Light therapy for fungal eye infection

This study tests a new light-based treatment for a rare fungal infection of the eye (Fusarium keratitis) that can cause vision loss. It aims to see if this therapy can fight the infection and help preserve or improve your vision.

Palo Alto, California
NCT06213649Recruiting· Phase 3
Ulcer treatment trial for active eye infection

This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.

San Francisco, California
NCT07169695Recruiting· Phase 2
Comparing a new eye drop to cyclosporine for eye allergy in kids

This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.

Kolkata, West Bengal
NCT06766357Recruiting· Phase 3
Cyclosporin gel for moderate to severe dry eye

This study tests a gel form of cyclosporine for people with moderate to severe dry eye that hasn't improved with other treatments. The gel is applied to the eye to help reduce inflammation and increase tear production.

Xiamen, Fujian
NCT07308938Not yet recruiting· Phase 2
Testing steroid eye drops for bacterial corneal ulcers

This study tests whether an anti-swelling eye drop (fluorometholone) helps people with bacterial eye ulcers heal faster when added to standard antibiotics. It may be an option if you have a bacterial ulcer and have already started antibiotic drops.

Pittsburgh, Pennsylvania

Hear when a new Corneal Ulcer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.